HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bourbon, A. Articles by Gandjbakhch, I. Search for Related Content PubMed PubMed Citation Articles by Bourbon, A. Articles by Gandjbakhch, I. Related Collections Cardiac - pharmacology Cardiac - other Extracorporeal circulation

Eur J Cardiothorac Surg 2004;26:932-938
© 2004 Elsevier Science NL

The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response

^a Service de chirurgie thoracique et cardio-vasculaire, Groupe Hospitalier Pitié-Salpêtrière, 47-83 Boulevard de l'hôpital, 75013 Paris, France
^b Laboratoire central d'immunologie cellulaire et tissulaire, UMR 7627 Groupe Hospitalier Pitié-Salpêtrière, 47-83 Boulevard de l'hôpital, 75013 Paris, France
^c Section of Cardiovascular and Thoracic Surgery, Department of Surgery, University of Arizona Health Science Center, Tucson, AZ 85724, USA

Received 11 August 2003; received in revised form 18 May 2004; accepted 1 July 2004.

^* Corresponding author. Tel.: +33-1-42165632; fax: +33-1-42165602. (E-mail: pascal.leprince{at}psl.ap-hop-paris.fr).

Objective: Cardiac surgery with cardiopulmonary bypass (CPB) is associated with an inflammatory response caused by contact of blood with artificial surfaces of the extracorporeal circuit, ischemia-reperfusion injury, and release of endotoxin. The inflammatory reaction involves activation of complement leucocytes, and endothelial cells with secretion of cytokines, proteases, arachidonic acid metabolites, and generation of oxygen derived free radicals (OFR) by polymorphonuclear neutrophils (PMN). Although this inflammatory response to CPB often remains at subclinical levels, it can also lead to major organ dysfunction. A number of studies have demonstrated that treatment of patients with a high-dose (30mg/kg) of corticosteroids (methylprednisolone) attenuates the CPB-induced SIR and improves the outcome of patients undergoing cardiac surgery. However, large doses of steroids can cause abnormal metabolic responses such as metabolic acidosis and hyperglycemia. In the present study, we examined the efficacy of low doses of methylprednisolone (5 and 10mg/kg) to attenuate the CPB-induced inflammatory response, during and after heart operations. Methods: Thirty-six adult patients undergoing cardiac surgery, were randomized into three groups: (1) control group: group A; (2) methylprednisolone, 5mg/kg body weight: group B; and (3) methylprednisolone, 10mg/kg body weight: group C. Plasma levels of the cytokines interleukin-6 (IL-6) and TNF- were analyzed by enzyme-linked immunosorbent assay, before, during, and after CPB. OFR production was determined by cytofluorometry (FACS) at the same end points. Results: No significant differences in age, body weight, CPB time, and cross-clamp time were observed among the three groups. CPB induced a marked increased in cytokine release and OFR generation. Low-dose of methylprednisolone (5mg/kg) effectively reduced the increase in TNF- and IL-6 secretion (P<0.05 compared to control group) after release of the cross-clamp. However, OFR generation was significantly reduced with a greater dose of methylprednisolone (10mg/kg). Conclusions: The results indicate that a single low-dose of methylprednisolone (10mg/kg) reduces the inflammatory reaction during and after CPB, by inhibition of proinflammatory cytokine release and OFR generation after release of the aortic cross-clamp.

This article has been cited by other articles:

				R. P. Whitlock, S. Chan, P.J. Devereaux, J. Sun, F. D. Rubens, K. Thorlund, and K. H.T. Teoh Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials Eur. Heart J., July 28, 2008; (2008) ehn333v1. [Abstract] [Full Text] [PDF]

				G. D. Karth, A. Buberl, M. Nikfardjam, B. Meyer, G. Wollenek, M. Grimm, A. Lassnigg, W. Brannath, M. Hiesmayr, and G. Heinz Role of amiodarone on the systemic inflammatory response induced by cardiac surgery: proinflammatory actions: [Role de l'amiodarone sur la reaction inflammatoire systemique provoquee par la chirurgie cardiaque : actions pro-inflammatoires] Can J Anesth, April 1, 2007; 54(4): 262 - 268. [Abstract] [Full Text] [PDF]

				O. J. Liakopoulos, N. Teucher, C. Muhlfeld, P. Middel, G. Heusch, F. A. Schoendube, and H. Dorge Prevention of TNFalpha-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment. Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 263 - 270. [Abstract] [Full Text] [PDF]

				C.-H. Hsing, M.-Y. Hsieh, W.-Y. Chen, E. Cheung So, B.-C. Cheng, and M.-S. Chang Induction of Interleukin-19 and Interleukin-22 After Cardiac Surgery With Cardiopulmonary Bypass Ann. Thorac. Surg., June 1, 2006; 81(6): 2196 - 2201. [Abstract] [Full Text] [PDF]

				F. L. Hanley Religion, politics...deep hypothermic circulatory arrest J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1236 - 1236. [Full Text] [PDF]

				L. Gao, R. Taha, D. Gauvin, L. B. Othmen, Y. Wang, and G. Blaise Postoperative Cognitive Dysfunction After Cardiac Surgery Chest, November 1, 2005; 128(5): 3664 - 3670. [Abstract] [Full Text] [PDF]

				S. Ener and M. Yilmaz The effect of single low-dose methylprednisolone on the cardiopulmonary bypass-induced inflammatory response Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 729 - 730. [Full Text] [PDF]